Apley M
Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, USA.
Vet Clin North Am Food Anim Pract. 1997 Nov;13(3):549-74. doi: 10.1016/s0749-0720(15)30313-3.
Our challenge in therapy of BRD is the selection of the appropriate therapy from antimicrobials with long-standing histories and newer compounds. The proliferation of new antimicrobials for BRD makes it difficult to justify the extralabel use of nonlabeled compounds. Evaluation of the BRD case definition and treatment population should be the first steps in selecting therapy and evaluating incidences of poor response.
我们在牛呼吸道疾病（BRD）治疗方面面临的挑战是，要从有着长期使用历史的抗菌药物和新型化合物中选择合适的治疗方法。用于BRD的新型抗菌药物不断涌现，这使得证明非标签化合物的超说明书使用合理性变得困难。评估BRD的病例定义和治疗人群应是选择治疗方法和评估治疗反应不佳发生率的首要步骤。
